Cargando…

AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300

Viral infection triggers a series of signaling cascades and host innate immune responses, including interferon (IFN) production, which depends on coordinated activity of multiple transcription factors. IFN regulatory factor 3 (IRF3) and transcriptional coactivator CREB binding protein (CBP) and/or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shengyu, Sun, Xin, Yi, Chenyang, Zhang, Dan, Lin, Xian, Sun, Xiaomei, Chen, Huanchun, Jin, Meilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438986/
https://www.ncbi.nlm.nih.gov/pubmed/28589097
http://dx.doi.org/10.3389/fcimb.2017.00195
_version_ 1783237863177977856
author Wang, Shengyu
Sun, Xin
Yi, Chenyang
Zhang, Dan
Lin, Xian
Sun, Xiaomei
Chen, Huanchun
Jin, Meilin
author_facet Wang, Shengyu
Sun, Xin
Yi, Chenyang
Zhang, Dan
Lin, Xian
Sun, Xiaomei
Chen, Huanchun
Jin, Meilin
author_sort Wang, Shengyu
collection PubMed
description Viral infection triggers a series of signaling cascades and host innate immune responses, including interferon (IFN) production, which depends on coordinated activity of multiple transcription factors. IFN regulatory factor 3 (IRF3) and transcriptional coactivator CREB binding protein (CBP) and/or p300 are core factors that participate in transcriptional complex formation in the nucleus. In general, cells balance the production of IFNs through suppressive and stimulative mechanisms, but viral infections can disrupt such equilibrium. This study determined that H5N1 viral infection reduced the distribution of human argonaute 2 (AGO2) in A549 cell nucleus. AGO2 did not block phosphorylation, nuclear translocation, and DNA binding ability of IRF3 but inhibited its association with CBP. Therefore, this newly revealed mechanism shows that cellular response leads to transfer of AGO2 from cell nucleus and promotes IFN-β expression to increase host survival during viral infection.
format Online
Article
Text
id pubmed-5438986
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54389862017-06-06 AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300 Wang, Shengyu Sun, Xin Yi, Chenyang Zhang, Dan Lin, Xian Sun, Xiaomei Chen, Huanchun Jin, Meilin Front Cell Infect Microbiol Microbiology Viral infection triggers a series of signaling cascades and host innate immune responses, including interferon (IFN) production, which depends on coordinated activity of multiple transcription factors. IFN regulatory factor 3 (IRF3) and transcriptional coactivator CREB binding protein (CBP) and/or p300 are core factors that participate in transcriptional complex formation in the nucleus. In general, cells balance the production of IFNs through suppressive and stimulative mechanisms, but viral infections can disrupt such equilibrium. This study determined that H5N1 viral infection reduced the distribution of human argonaute 2 (AGO2) in A549 cell nucleus. AGO2 did not block phosphorylation, nuclear translocation, and DNA binding ability of IRF3 but inhibited its association with CBP. Therefore, this newly revealed mechanism shows that cellular response leads to transfer of AGO2 from cell nucleus and promotes IFN-β expression to increase host survival during viral infection. Frontiers Media S.A. 2017-05-22 /pmc/articles/PMC5438986/ /pubmed/28589097 http://dx.doi.org/10.3389/fcimb.2017.00195 Text en Copyright © 2017 Wang, Sun, Yi, Zhang, Lin, Sun, Chen and Jin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Wang, Shengyu
Sun, Xin
Yi, Chenyang
Zhang, Dan
Lin, Xian
Sun, Xiaomei
Chen, Huanchun
Jin, Meilin
AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title_full AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title_fullStr AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title_full_unstemmed AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title_short AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300
title_sort ago2 negatively regulates type i interferon signaling pathway by competition binding irf3 with cbp/p300
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438986/
https://www.ncbi.nlm.nih.gov/pubmed/28589097
http://dx.doi.org/10.3389/fcimb.2017.00195
work_keys_str_mv AT wangshengyu ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT sunxin ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT yichenyang ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT zhangdan ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT linxian ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT sunxiaomei ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT chenhuanchun ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300
AT jinmeilin ago2negativelyregulatestypeiinterferonsignalingpathwaybycompetitionbindingirf3withcbpp300